| Niu, Junqi |
| Active, not recruiting | 4 | 640 | RoW | Tenofovir Amibufenamide（TMF）, HS-10234 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Hepatitis B, Chronic | 06/24 | 09/29 | | |
NCT06715319: Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis |
|
|
| Completed | 3 | 100 | RoW | OCA, Obeticholic Acid, UDCA, Placebo | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | PBC | 10/23 | 04/24 | | |
NCT04543565: Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study |
|
|
| Recruiting | 3 | 900 | RoW | Pradefovir Mesylate;Placebo of Tenofovir disoproxil fumarate tablet, Tenofovir disoproxil fumarate tablet;Placebo of Pradefovir Mesylate | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Chronic Hepatitis b | 10/22 | 12/24 | | |
NCT04956328: Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC) |
|
|
| Recruiting | 3 | 120 | RoW | Obeticholic Acid Tablets, UDCA, Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Primary Biliary Cirrhosis | 09/23 | 09/23 | | |
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( ) |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | IVA337, Lanifibranor, Placebo | Inventiva Pharma | NASH - Nonalcoholic Steatohepatitis | 09/25 | 09/26 | | |
| Active, not recruiting | 3 | 871 | Europe, Canada, Japan, US, RoW | Bepirovirsen, Placebo | GlaxoSmithKline, GlaxoSmithKline Research & Development Limited | Chronic Hepatitis B, Hepatitis B, Chronic | 11/25 | 05/26 | | |
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C |
|
|
| Recruiting | 2/3 | 520 | RoW | HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo | Sunshine Lake Pharma Co., Ltd. | Chronic HCV Infection | 04/23 | 04/23 | | |
NCT04278820: A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) |
|
|
| Not yet recruiting | 2a | 130 | RoW | TQA3526, Placebo to match TQA3526 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Primary Biliary Cirrhosis | 11/22 | 11/22 | | |
NCT05484466: A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB |
|
|
| Recruiting | 2a | 90 | RoW | ZM-H1505R, ZM-H1505R placebo, Baraclude | Shanghai Zhimeng Biopharma, Inc., Tigermed Consulting Co., Ltd | Hepatitis B, Chronic | 12/22 | 12/24 | | |
NCT04157257: An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy |
|
|
| Recruiting | 2 | 60 | RoW | TDF tablet, Tenofovir dipirofurate fumarate tablet, Entecavir Tablet, Entecavir, QL-007, QL-007 tablet | Qilu Pharmaceutical Co., Ltd. | Chronic Hepatitis b | 12/20 | 10/22 | | |
NCT04157699: An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b |
|
|
| Recruiting | 2 | 100 | RoW | TDF tablet, Tenofovir disoproxil fumarate tablet, QL-007 | Qilu Pharmaceutical Co., Ltd. | Chronic Hepatitis b | 12/20 | 10/22 | | |
NCT05734807: A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia |
|
|
| Completed | 2 | 74 | RoW | Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003, NrtIs and PEG-IFN-α | Huahui Health | Chronic HBV Infection | 04/24 | 04/24 | | |
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection |
|
|
| Completed | 2 | 250 | RoW | GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table | Sunshine Lake Pharma Co., Ltd. | Chronic HBV Infection | 06/22 | 09/23 | | |
NCT05637541: Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets |
|
|
| Recruiting | 2 | 90 | RoW | GST-HG141 | Fujian Akeylink Biotechnology Co., Ltd. | Chronic Hepatitis b | 08/23 | 12/23 | | |
NCT05827146: Study of Hepalatide in Chronic Hepatitis D(CHD) Patients |
|
|
| Completed | 2 | 23 | RoW | Hepalatide, L47, Hepalatide Placebo, Placebo | Shanghai HEP Pharmaceutical Co., Ltd. | Chronic Hepatitis D Infection | 01/24 | 02/24 | | |
NCT05193916: A Phase II Clinical Trial of Chiglitazar for NASH |
|
|
| Completed | 2 | 104 | RoW | chiglitazar sodium tablets, Bilessglu®, CS-038, Carfloglitazar, Placebo, simulant of chiglitazar | Chipscreen Biosciences, Ltd. | NASH | 01/24 | 01/24 | | |
NCT06550128: Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Subjects With Chronic Hepatitis B (CHB). |
|
|
| Active, not recruiting | 2 | 60 | RoW | AHB-137 injection, Placebo | Ausper Biopharma Co., Ltd. | Hepatitis B, Chronic | 04/25 | 06/26 | | |
NCT05689645: F573 for Injection for the Treatment of Liver Injury/Failure |
|
|
| Recruiting | 2 | 97 | RoW | F573 for injection, Sterilizing water for injection | Beijing Continent Pharmaceutical Co, Ltd. | Acute Liver Failure, Acute-On-Chronic Liver Failure | 09/25 | 03/26 | | |
NCT06115993: A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients |
|
|
| Active, not recruiting | 1/2 | 270 | RoW | AHB-137 injection, Placebo | Ausper Biopharma Co., Ltd. | Hepatitis B, Chronic | 12/24 | 01/26 | | |
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B |
|
|
| Not yet recruiting | 1/2 | 162 | RoW | TQA3038 injection/placebo, Nucleotide drugs Control group | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatitis B, Chronic | 09/26 | 09/26 | | |
NCT04499443: Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets |
|
|
| Recruiting | 1 | 124 | RoW | GST-HG131 tablets, Placebo | Fujian Cosunter Pharmaceutical Co. Ltd | Hepatitis B | 03/21 | 05/21 | | |
NCT05391360: Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study |
|
|
| Completed | 1 | 128 | RoW | Freethiadine tablets(part I), Freethiadine tablets (part II), Freethiadine placebo tablets, entecavir tablets | Sunshine Lake Pharma Co., Ltd. | Hepatitis B, Chronic | 01/23 | 01/23 | | |
NCT03108794: A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B |
|
|
| Recruiting | N/A | 200000 | RoW | | Beijing Friendship Hospital, Beijing YouAn Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Beijing Ditan Hospital, First Affiliated Hospital of Xinjiang Medical University, LanZhou University, The Second Affiliated Hospital of Chongqing Medical University, West China Hospital, Taiyuan No.3 Hospital, Hebei Medical University Third Hospital, Shengjing Hospital, Tianjin Third Central Hospital, Peking University First Hospital, Peking Union Medical College Hospital, The Affiliated Hospital Of Southwest Medical University, Shanghai Public Health Clinical Center, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xiangya Hospital of Central South University, Beijing Tiantan Hospital, Wuhan University, The First Affiliated Hospital of Kunming Medical College, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Hospital of Yanbian University, First Affiliated Hospital of Chongqing Medical University, The Fouth Hospital of Qinghai province, Weifang Medical University, Hunan Provincial People's Hospital, The Second Hospital of Hebei Medical University, Xixi Hospital of Hangzhou, General Hospital of Ningxia Medical University, Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Peking University People's Hospital, Nanfang Hospital of Southern Medical University, The Affiliated Hospital Of Guizhou Medical University, Guizhou Provincial People's Hospital, Hainan General Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Fifth Hospital of Shijiazhuang City, Yan'an University Affiliated Hospital, Infectious Disease Hospital of Wuhai, Logistics University of Chinese People's Armed Police Forces, People's Hospital of Changji Hui Autonomous Prefecture，Xinjiang | Chronic Hepatitis B | 12/22 | 12/25 | | |
NCT06525909: A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B |
|
|
| Recruiting | N/A | 250 | RoW | | Tongji Hospital | Hepatitis B, Chronic | 12/26 | 12/28 | | |
